B one tumors include benign, intermediate, and malignant lesions, according to the classification system of the World Health Organization (1). Malignant neoplasms can be further divided into primary and secondary bone tumors or metastases (2,3). Radiography is the suggested primary imaging modality for the diagnosis of bone tumors because it can enable visualization of the location, destruction pattern, and periosteal reaction pattern of bone lesions (4,5). These destruction patterns reflect the biologic activity of bone lesions, through which they can be categorized as aggressive or nonaggressive (6). As demonstrated by Lodwick's well-established grading system, the destruction patterns of bone tumors observed on radiographs allow for evaluation of biologic activity and subsequently allow for risk assessment of malignancy (7,8). Primary bone tumors are uncommon. Thus, many radiologists may not be able to develop sufficient expertise to reliably identify and assess these lesions on radiographs (9). However, early detection and correct diagnosis are crucial for adequate and successful treatment (10). To improve the rates of early detection and correct assessment, an artificial intelligence model that could detect and accurately categorize bone lesions into malignant or benign bone lesions on radiographs may be beneficial. Recently, studies have shown that deep learning (DL) models reliably assess and detect a variety of diseases based on medical imaging data (11,12). Clinical implementation of these models may improve the reliability and accuracy of radiologic assessment, thus potentially leading to improved diagnostics and better patient outcomes (13). Recently, a preliminary study used DL to classify primary bone tumors on radiographs ( 14), but Background: An artificial intelligence model that assesses primary bone tumors on radiographs may assist in the diagnostic workflow.Purpose: To develop a multitask deep learning (DL) model for simultaneous bounding box placement, segmentation, and classification of primary bone tumors on radiographs. Materials and Methods:This retrospective study analyzed bone tumors on radiographs acquired prior to treatment and obtained from patient data from January 2000 to June 2020. Benign or malignant bone tumors were diagnosed in all patients by using the histopathologic findings as the reference standard. By using split-sample validation, 70% of the patients were assigned to the training set, 15% were assigned to the validation set, and 15% were assigned to the test set. The final performance was evaluated on an external test set by using geographic validation, with accuracy, sensitivity, specificity, and 95% CIs being used for classification, the intersection over union (IoU) being used for bounding box placements, and the Dice score being used for segmentations. Results:Radiographs from 934 patients (mean age, 33 years 6 19 [standard deviation]; 419 women) were evaluated in the internal data set, which included 667 benign bone tumors and 267 malignant bone tumors. Six hundred f...
Disclosures of Conflicts of Interest: C.E.v.S. disclosed no relevant relationships. J.H.S. disclosed no relevant relationships. F.L. disclosed no relevant relationships. E.O. disclosed no relevant relationships. P.M.J. disclosed no relevant relationships. L.N. disclosed no relevant relationships. M.P. disclosed no relevant relationships. S.C.F. disclosed no relevant relationships. M.C.N. disclosed no relevant relationships. T.M.L. disclosed no relevant relationships. V.P. disclosed no relevant relationships.
Though cognitive function is proven to be an independent predictor of survival in patients with intrinsic brain tumors, cognitive functions are still rarely considered. Aim of this study was to assess neurocognitive function and to identify risk factors for neurocognitive deficits. 103 patients with primary neuroepithelial tumors who received tumor resections or biopsies were included in this prospective study. The following data was acquired: mini-mental state examination, preoperative tumor volume, WHO grade, tumor entity and location, and the Karnofsky performance status scale. Furthermore, patients participated in extensive neuropsychological testing of attentional, memory and executive functions. General factors like age, clinical status, WHO grade, tumor volume and tumor location correlated with patients’ neurocognitive functions. Affection of the parietal lobe resulted in significant impairment of attention and memory functions. Frontal lobe involvement significantly affected patients’ abilities in planning complex actions and novel problem solving. Patients with temporal lesions were more likely to have impaired memory and executive functions. Comparing results among neuroepithelial tumor patients enables the identification of risk factors for cognitive impairment. General parameters such as age, KPS score, tumor size, and WHO grade are apart from the respective tumor location of high importance for neurocognitive function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.